Loading…
Reported covered position: None
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safeguarding America's Pharmaceuticals Act of 2011
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)
Health Care Cost Reduction Act of 2012
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2012 · fourth_quarter · Q4
S. 3187, "Food and Drug Administration Safety and Innovation Act", (Draft comments by bicameral staff; provisions relating to pharmaceutical distribution integrity not included in the final bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2012 · third_quarter · Q3
Source: Senate LDA
H.R. 436, "Health Care Cost Reduction Act of 2012"" (All provisions, including but not limited to Section 2, related to the Repeal of the Medical Device Tax) General issues related to the retention of last-in, first-out inventory accounting methods.
Safeguarding America's Pharmaceuticals Act of 2011
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
HR 3026, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System)
Safeguarding America's Pharmaceuticals Act of 2011
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)
Health Care Cost Reduction Act of 2012
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
HR 436, "Protect Medical Innovations Act of 2011" (all provisions) HR 5839, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System and Section 8, Requirements for Licensure of Wholesale Distributors)
Disaster Savings and Resilient Construction Act of 2012
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
HR 436, "Protect Medical Innovations Act of 2011" (all provisions) HR 5839, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System and Section 8, Requirements for Licensure of Wholesale Distributors)
S. 3187, "Food and Drug Administration Safety and Innovation Act", (Draft comments by Senate staff; provisions relating to pharmaceutical distribution integrity not included in the final bill) S. 2997, "To amend the Controlled Substances Act to make any substance containing hydrocodone a Schedule II drug". (All sections)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2012 · second_quarter · Q2
H.R. 436, "Health Care Cost Reduction Act of 2012"" (All provisions, including but not limited to Section 2, related to the Repeal of the Medical Device Tax) General issues related to the retention of last-in, first-out inventory accounting methods.
S. 3187, "Food and Drug Administration Safety and Innovation Act", (Draft comments by Senate staff; provisions relating to pharmacetuical distribution integrity not included in the final bill) S. 2997, "To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug". (All sections)
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2012 · first_quarter · Q1
H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2011 · fourth_quarter · Q4
H.R. 3026, "Securing America's Pharmaceuticals Act" (All provisions, including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking Systems)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2011 · fourth_quarter · Q4
HR 3026, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Drug Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2011 · third_quarter · Q3
General issues related to the retention of last-in, first-out inventory accounting methodology
HR 436, "Protect Medical Innovations Act of 2011" (all provisions) HR 5839, "Securing America's Pharmaceuticals Act" (All provisions including but not limited to Section 4, related to Interim Provisions to Assure the Safety of the Wholesale Distribution of Prescription Drugs, Section 6 related to Prescription Drug Identification and Tracking System and Section 8, Requirements for Licensure of Wholesale Distributors)
Filing targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE